Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Female Breast Carcinoma × Fulvestrant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 144 Neoplasm Metastasis 16 Neoplasms 8 Advanced Breast Cancer 8 Ovarian Neoplasms 7 Carcinoma, Non-Small-Cell Lung 6 Prostatic Neoplasms 5 Breast Cancer Metastatic 5 Endometrial Neoplasms 4 Recurrence 3 Hereditary Sensory and Autonomic Neuropathies 3 Lung Neoplasms 2 Hyperglycemia 2 Exanthema 2 Estrogen Receptor-positive Breast Cancer 2 Colorectal Neoplasms 2 Carcinoma, Lobular 2 Breast Neoplasms, Male 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sex Cord-Gonadal Stromal Tumors 1 Sarcoma, Endometrial Stromal 1 Salivary Gland Neoplasms 1 Recurrent Uterine Corpus Carcinoma 1 Pancreatic Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02540330 2024-04-03

007

Atossa Therapeutics, Inc.

Phase 2 Terminated

3 enrolled 7 charts

Female Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡